Literature DB >> 25571973

p73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling.

R Fernandez-Alonso1, M Martin-Lopez1, L Gonzalez-Cano1, S Garcia1, F Castrillo1, I Diez-Prieto2, A Fernandez-Corona3, M E Lorenzo-Marcos3, X Li4, L Claesson-Welsh4, M M Marques5, M C Marin1.   

Abstract

Vasculogenesis, the establishment of the vascular plexus and angiogenesis, branching of new vessels from the preexisting vasculature, involves coordinated endothelial differentiation, proliferation and migration. Disturbances in these coordinated processes may accompany diseases such as cancer. We hypothesized that the p53 family member p73, which regulates cell differentiation in several contexts, may be important in vascular development. We demonstrate that p73 deficiency perturbed vascular development in the mouse retina, decreasing vascular branching, density and stability. Furthermore, p73 deficiency could affect non endothelial cells (ECs) resulting in reduced in vivo proangiogenic milieu. Moreover, p73 functional inhibition, as well as p73 deficiency, hindered vessel sprouting, tubulogenesis and the assembly of vascular structures in mouse embryonic stem cell and induced pluripotent stem cell cultures. Therefore, p73 is necessary for EC biology and vasculogenesis and, in particular, that DNp73 regulates EC migration and tube formation capacity by regulation of expression of pro-angiogenic factors such as transforming growth factor-β and vascular endothelial growth factors. DNp73 expression is upregulated in the tumor environment, resulting in enhanced angiogenic potential of B16-F10 melanoma cells. Our results demonstrate, by the first time, that differential p73-isoform regulation is necessary for physiological vasculogenesis and angiogenesis and DNp73 overexpression becomes a positive advantage for tumor progression due to its pro-angiogenic capacity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25571973      PMCID: PMC4495354          DOI: 10.1038/cdd.2014.214

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  61 in total

Review 1.  Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

Authors:  Lynn Hlatky; Philip Hahnfeldt; Judah Folkman
Journal:  J Natl Cancer Inst       Date:  2002-06-19       Impact factor: 13.506

2.  Microfabrication-based modulation of embryonic stem cell differentiation.

Authors:  Jaesung Park; Cheul H Cho; Natesh Parashurama; Yawen Li; François Berthiaume; Mehmet Toner; Arno W Tilles; Martin L Yarmush
Journal:  Lab Chip       Date:  2007-06-13       Impact factor: 6.799

Review 3.  TGF-beta signaling in vascular biology and dysfunction.

Authors:  Marie-José Goumans; Zhen Liu; Peter ten Dijke
Journal:  Cell Res       Date:  2009-01       Impact factor: 25.617

4.  VEGF receptor signal transduction.

Authors:  Xiujuan Li; Lena Claesson-Welsh; Masabumi Shibuya
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

Review 5.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

6.  Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.

Authors:  Genta Narazaki; Hideki Uosaki; Mizue Teranishi; Keisuke Okita; Bongju Kim; Satoshi Matsuoka; Shinya Yamanaka; Jun K Yamashita
Journal:  Circulation       Date:  2008-07-14       Impact factor: 29.690

Review 7.  Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis.

Authors:  Matthew T Holderfield; Christopher C W Hughes
Journal:  Circ Res       Date:  2008-03-28       Impact factor: 17.367

Review 8.  DNp73 a matter of cancer: mechanisms and clinical implications.

Authors:  Sven Buhlmann; Brigitte M Pützer
Journal:  Biochim Biophys Acta       Date:  2008-02-12

9.  Deficiency of the E3 ubiquitin ligase TRIM32 in mice leads to a myopathy with a neurogenic component.

Authors:  Elena Kudryashova; Jun Wu; Leif A Havton; Melissa J Spencer
Journal:  Hum Mol Genet       Date:  2009-01-19       Impact factor: 6.150

10.  TAp73 knockout shows genomic instability with infertility and tumor suppressor functions.

Authors:  Richard Tomasini; Katsuya Tsuchihara; Margareta Wilhelm; Masashi Fujitani; Alessandro Rufini; Carol C Cheung; Fatima Khan; Annick Itie-Youten; Andrew Wakeham; Ming-Sound Tsao; Juan L Iovanna; Jeremy Squire; Igor Jurisica; David Kaplan; Gerry Melino; Andrea Jurisicova; Tak W Mak
Journal:  Genes Dev       Date:  2008-09-19       Impact factor: 11.361

View more
  27 in total

Review 1.  Clinical implications of the deregulated TP73 isoforms expression in cancer.

Authors:  N Rodríguez; A Peláez; R Barderas; G Domínguez
Journal:  Clin Transl Oncol       Date:  2017-12-11       Impact factor: 3.405

2.  Hypoxia-inducible TAp73 supports tumorigenesis by regulating the angiogenic transcriptome.

Authors:  Iqbal Dulloo; Beng Hooi Phang; Rashidah Othman; Soo Yong Tan; Aadhitthya Vijayaraghavan; Liang Kee Goh; Marta Martin-Lopez; Margarita M Marques; Chun Wei Li; De Yun Wang; Maria Carmen Marín; Wa Xian; Frank McKeon; Kanaga Sabapathy
Journal:  Nat Cell Biol       Date:  2015-03-16       Impact factor: 28.824

Review 3.  p73 isoforms meet evolution of metastasis.

Authors:  Stella Logotheti; Athanasia Pavlopoulou; Stephan Marquardt; Işıl Takan; Alexandros G Georgakilas; Thorsten Stiewe
Journal:  Cancer Metastasis Rev       Date:  2022-08-11       Impact factor: 9.237

4.  In-depth proteomics characterization of ∆Np73 effectors identifies key proteins with diagnostic potential implicated in lymphangiogenesis, vasculogenesis and metastasis in colorectal cancer.

Authors:  María Garranzo-Asensio; Javier Rodríguez-Cobos; Coral San Millán; Carmen Poves; María Jesús Fernández-Aceñero; Daniel Pastor-Morate; David Viñal; Ana Montero-Calle; Guillermo Solís-Fernández; María-Ángeles Ceron; Manuel Gámez-Chiachio; Nuria Rodríguez; Ana Guzmán-Aránguez; Rodrigo Barderas; Gemma Domínguez
Journal:  Mol Oncol       Date:  2022-06-07       Impact factor: 7.449

5.  Association between TAp73, p53 and VASH1 expression in lung adenocarcinoma.

Authors:  Meng Wu; Zhihua Zhang; Fangxu Ma; Xiulong Zhang; Zhilin Zhang; Jianhua Tang; Ping Chen; Chunyan Zhou; Weiping Wang
Journal:  Oncol Lett       Date:  2018-01-31       Impact factor: 2.967

Review 6.  Tissue-specific roles of p73 in development and homeostasis.

Authors:  Alice Nemajerova; Ute M Moll
Journal:  J Cell Sci       Date:  2019-10-03       Impact factor: 5.285

7.  p73 Regulates Primary Cortical Neuron Metabolism: a Global Metabolic Profile.

Authors:  Massimiliano Agostini; Maria Victoria Niklison-Chirou; Margherita Maria Annicchiarico-Petruzzelli; Sandro Grelli; Nicola Di Daniele; Ilias Pestlikis; Richard A Knight; Gerry Melino; Alessandro Rufini
Journal:  Mol Neurobiol       Date:  2017-05-06       Impact factor: 5.590

8.  Conditional ablation of p63 indicates that it is essential for embryonic development of the central nervous system.

Authors:  Gonzalo I Cancino; Michael P Fatt; Freda D Miller; David R Kaplan
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

9.  Novel role of p73 as a regulator of developmental angiogenesis: Implication for cancer therapy.

Authors:  Maria C Marin; Margarita M Marques
Journal:  Mol Cell Oncol       Date:  2015-05-26

10.  Mesenchymal Stem Cells Differentiate to Endothelial Cells Using Recombinant Vascular Endothelial Growth Factor -A.

Authors:  Mohsen Khaki; Ali Hatef Salmanian; Hamid Abtahi; Ali Ganji; Ghasem Mosayebi
Journal:  Rep Biochem Mol Biol       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.